DrugPatentWatch Database Preview
HORIZANT Drug Profile
Which patents cover Horizant, and when can generic versions of Horizant launch?
Horizant is a drug marketed by Arbor Pharms Llc and is included in one NDA. There are six patents protecting this drug.
This drug has one hundred and forty-seven patent family members in twenty-five countries.
The generic ingredient in HORIZANT is gabapentin enacarbil. There are twenty-nine drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the gabapentin enacarbil profile page.
Summary for HORIZANT
International Patents: | 147 |
US Patents: | 6 |
Applicants: | 1 |
NDAs: | 1 |
Suppliers / Packagers: | 1 |
Bulk Api Vendors: | 36 |
Clinical Trials: | 10 |
Patent Applications: | 75 |
Formulation / Manufacturing: | see details |
Drug Prices: | Drug price information for HORIZANT |
DailyMed Link: | HORIZANT at DailyMed |

Generic Entry Opportunity Date for HORIZANT
Generic Entry Date for HORIZANT*:
Constraining patent/regulatory exclusivity:
NDA:
Dosage:
TABLET, EXTENDED RELEASE;ORAL |
*The generic entry opportunity date is the latter of the last compound-claiming patent and the last regulatory exclusivity protection. Many factors can influence early or later generic entry. This date is provided as a rough estimate of generic entry potential and should not be used as an independent source.
Pharmacology for HORIZANT
Drug Class | Anti-epileptic Agent |
Physiological Effect | Decreased Central Nervous System Disorganized Electrical Activity |
Synonyms for HORIZANT
(1-(((((1RS)-1-((2-methylpropanoyl)oxy)ethoxy)carbonyl)amino)methyl)cyclohexyl)acetic acid |
{[(1-Isobutanoyloxyethoxy)carbonyl]aminomethyl}-1-Cyclohexane Acetic Acid |
{[(alpha-Isobutanoyloxyethoxy)carbonyl]aminomethyl}-1-Cyclohexane Acetic Acid |
{1-[({[1-(isobutyryloxy)ethoxy]carbonyl}amino)methyl]cyclohexyl}acetic acid |
1-[[[[1-(2-Methyl-1-oxopropoxy)ethoxy]carbonyl]amino]methyl]cyclohexaneacetic acid |
1-{[(alpha-Isobutanovloxyethoxy)carbonyl]aminomethyl}-1-Cyclohexane Acetic Acid |
1-{[(alpha-Isobutanoyloxyethoxy)carbonyl]aminomethyl}-1-Cyclohexane Acetic Acid |
1-{[(alpha-isobutanoyloxyethoxy)carbonyl]aminomethyl}-1-cyclohexaneacetic acid |
2-(1-((((1-(Isobutyryloxy)ethoxy)carbonyl)amino)methyl)cyclohexyl)acetic acid |
2-(1-(((1-(isobutyryloxy)ethoxy)carbonyl)methyl)cyclohexyl)acetic acid |
2-(1-(((1-(isobutyryloxy)ethoxy)carbonylamino)methyl)cyclohexyl)acetic acid |
2-[1-[[[1-[(2-Methylpropanoyl)oxy]ethoxy]carbonylamino]methyl]cyclohexyl]acetic acid |
2-[1-[[1-(2-methylpropanoyloxy)ethoxycarbonylamino]methyl]cyclohexyl]acetic acid |
296G729 |
3687AH |
478296-72-9 |
791632-57-0 |
A20372 |
AC-27644 |
ACN-028536 |
AK170416 |
AKOS025290727 |
AN-16701 |
API0008802 |
ASP-8825 |
ASP8825 |
CHEBI:68840 |
CHEMBL1628502 |
CS-1698 |
Cyclohexaneacetic acid, 1-((((1-(2-methyl-1-oxopropoxy)ethoxy)carbonyl)amino)methyl)- |
Cyclohexaneacetic acid,1-[[[[1-(2-methyl-1-oxopropoxy)ethoxy]carbonyl]amino]methyl]- |
D05KBU |
D09539 |
DB08872 |
FT-0753836 |
Gabapentin enacarbil |
Gabapentin enacarbil (JAN/USAN/INN) |
Gabapentin enacarbil [USAN:INN] |
Gabapentin-XP |
gabapentina enacarbilo |
gabapentine enacarbil |
Gabapentinenacarbil |
gabapentinum enacarbilum |
GSK 1838262 |
GSK-1838262 |
GSK1838262 |
GTPL7560 |
Horizant (TN) |
Horizant, Regnite |
Horizant|||Regnite|||XP 13512 |
HY-16216 |
MFCD09954124 |
OR068058 |
OR272863 |
PB32822 |
Q-1947 |
Regnite |
SCHEMBL25455 |
Solzira |
TZDUHAJSIBHXDL-UHFFFAOYSA-N |
XP 13512 |
XP-053 |
XP-13512 |
XP13512 |
US Patents and Regulatory Information for HORIZANT
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Arbor Pharms Llc | HORIZANT | gabapentin enacarbil | TABLET, EXTENDED RELEASE;ORAL | 022399-002 | Dec 13, 2011 | RX | Yes | No | ➤ Try a Free Trial | ➤ Try a Free Trial | Y | Y | ➤ Try a Free Trial | ||
Arbor Pharms Llc | HORIZANT | gabapentin enacarbil | TABLET, EXTENDED RELEASE;ORAL | 022399-001 | Apr 6, 2011 | RX | Yes | Yes | ➤ Try a Free Trial | ➤ Try a Free Trial | ➤ Try a Free Trial | ||||
Arbor Pharms Llc | HORIZANT | gabapentin enacarbil | TABLET, EXTENDED RELEASE;ORAL | 022399-002 | Dec 13, 2011 | RX | Yes | No | ➤ Try a Free Trial | ➤ Try a Free Trial | ➤ Try a Free Trial | ||||
Arbor Pharms Llc | HORIZANT | gabapentin enacarbil | TABLET, EXTENDED RELEASE;ORAL | 022399-001 | Apr 6, 2011 | RX | Yes | Yes | ➤ Try a Free Trial | ➤ Try a Free Trial | Y | ➤ Try a Free Trial | |||
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
International Patents for HORIZANT
Country | Document Number | Estimated Expiration |
---|---|---|
Hong Kong | 1104798 | ➤ Try a Free Trial |
Japan | 2006509031 | ➤ Try a Free Trial |
China | 101068538 | ➤ Try a Free Trial |
Taiwan | 200630086 | ➤ Try a Free Trial |
Country | Document Number | Estimated Expiration |